Magnetic Ventures is an early-stage venture capital firm founded in 2018 by Christine Aylward, focusing on transformative investments at the intersection of technology and healthcare. The firm specializes in seed and early-stage investments, primarily targeting companies in the healthcare, information technology, life sciences, and technology sectors across North America and Europe. Magnetic Ventures aims to support innovative ventures that have the potential to drive significant advancements in these fields.

The firm's portfolio includes companies such as Weave Bio, Relation Therapeutics, Resilience, Paradigm, Deep Genomics, and Terrain Biosciences, among others. Magnetic Ventures provides more than capital, offering extensive resources to accelerate growth and maximize impact. The firm has expertise in engineering, biology, genomics, and biotechnology and understands the complex dynamics of the healthcare sector.

They have extensive experience in regulatory and commercialization processes, having launched and scaled groundbreaking technologies. Magnetic Ventures invests in companies focusing on software tools, AI, ML, multiomics, drug discovery, and precision medicine, primarily in North America and Europe.